Results 231 to 240 of about 92,925 (293)

Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Immunotherapy targeting amyloid beta (Aβ) is limited by amyloid‐related imaging abnormalities (ARIA), hypothesized to result from the direct binding of anti‐Aβ monoclonal antibodies (mAbs) to vascular cerebral amyloid angiopathy (CAA), eliciting an immune response.
Martine B. Grenon   +5 more
wiley   +1 more source

Sleep‐like slow waves during resting‐state: A promising EEG biomarker of amyloid and neurodegeneration in preclinical Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Growing evidence supports a critical role of sleep slow waves (SW) in Alzheimer's disease (AD). However, wake SW (sleep‐like SW potentially reflecting local intrusions of sleep) remain unexplored in AD. METHODS A total of 274 older adults with subjective cognitive decline (SCD) (INSIGHT‐preAD cohort, 76.6 ± 3.5 years) underwent (i)
Pierre Champetier   +14 more
wiley   +1 more source

Familial hypobetalipoproteinemia in pediatric patients with fatty liver: an under-recognized cause. [PDF]

open access: yesFront Med (Lausanne)
Loberman Nachum N   +5 more
europepmc   +1 more source

Outcome‐specific risk factors challenge universal dementia prevention priorities: Findings from the Egyptian Dementia Network Registry

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Graphical Abstract illustrating how the different risk factors relate to dementia diagnosis and cognitive performance. Solid arrows indicate robust associations in this cohort; dashed arrows indicate weaker or imprecise associations. Abstract BACKGROUND Dementia prevention targets modifiable factors from high‐income cohorts, but most studies conflate ...
Shimaa A. Heikal   +13 more
wiley   +1 more source

Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION We investigated how plasma biomarkers (phosphorylated tau 217 [ptau217], glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) relate to imaging markers of small vessel disease (SVD) and Alzheimer's disease (AD), and cognition in memory clinic patients.
Anna Dewenter   +20 more
wiley   +1 more source

A functional SNP rs12718466 in APOA1 promoter modulates gene expression via interaction with SOX7. [PDF]

open access: yesJ Biol Chem
Aita Y   +15 more
europepmc   +1 more source

Age‐related increase in plasma p‐tau217 in amyloid‐beta–negative cognitively unimpaired individuals affects diagnostic interpretation

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION The extent to which non‐pathological aging influences plasma biomarkers remains unclear. Here, we investigate factors influencing plasma p‐tau217 levels in cognitively unimpaired (CU), amyloid‐beta–negative (Aβ‐) individuals. METHODS Plasma p‐tau217 was measured in CU Aβ‐ positron emission tomography–negative (PET‐) participants ...
Anna E Mammel   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy